a16z Podcast

The Science and Supply of GLP-1s

42 snips
Jun 19, 2024
Brooke Boyarsky-Pratt, the CEO of KnownWell, revolutionizes the obesity medicine landscape with her personal journey battling obesity. She discusses the critical role of obesity-specific practitioners and patient-centric medical homes in fostering trust. The conversation delves into the science and impact of GLP-1 medications, highlighting their tailored applications in treatment. The challenges of cost and supply in the obesity sector are addressed, alongside a vision for a more empathetic, comprehensive approach to obesity care.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

Brooke's Inspiration

  • Brooke Boyarsky-Pratt's pediatrician suggested "fat camp", negatively impacting her healthcare interactions.
  • This experience fueled her passion to create patient-centered care for individuals with obesity.
INSIGHT

Obesity Medicine Defined

  • Obesity medicine is a medical specialty focusing on comprehensive treatment of overweight and obesity.
  • It addresses weight loss and related conditions like diabetes and hyperlipidemia.
ADVICE

PCP Challenges

  • Primary care doctors often lack sufficient training and resources for effective obesity management.
  • They may struggle with medication understanding, approvals, and providing wraparound services.
Get the Snipd Podcast app to discover more snips from this episode
Get the app